AdaptHealth Corp. (NASDAQ:AHCO) Stock Has Average Price Target of $10.14 According to Brokerages

AdaptHealth Corp. (NASDAQ:AHCO) has been given a consensus recommendation of “Moderate Buy” by the nine ratings firms that are presently covering the firm, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and seven have assigned a buy recommendation to the company. The average 12 month price objective among brokers that have covered the stock in the last year is $10.00.

AHCO has been the subject of a number of research reports. Jefferies Financial Group raised shares of AdaptHealth from a “hold” rating to a “buy” rating and lifted their price objective for the stock from $11.00 to $13.00 in a report on Tuesday, July 21st. Wall Street Zen cut shares of AdaptHealth from a “hold” rating to a “sell” rating in a report on Sunday, August 16th. UBS Group dropped their target price on shares of AdaptHealth from $10.00 to $9.00 and set a “buy” rating on the stock in a report on Wednesday. Weiss Ratings restated a “sell (d)” rating on shares of AdaptHealth in a research report on Wednesday, August 19th. Finally, Canaccord Genuity Group set a $10.00 price target on shares of AdaptHealth in a report on Wednesday, August 5th.

AdaptHealth News Summary

Here are the key news stories impacting AdaptHealth this week:

• Positive Sentiment: AdaptHealth raised its 2026 adjusted EBITDA outlook to $510 million–$525 million and outlined a path to a 20% margin on its largest capitated contract by the fourth quarter of next year. The improved outlook and margin target may support investor confidence. Article
• Positive Sentiment: Third-quarter revenue of $745.65 million exceeded analyst expectations of $725.87 million, providing a notable bright spot in the report. Third-quarter results
• Neutral Sentiment: UBS cut its price target to $9 from $10 but maintained a Buy rating, leaving its view positive while signaling a lower valuation expectation. The revised target implies about 23% upside from the cited $7.31 share price. UBS rating information
• Neutral Sentiment: The company will participate in the UBS Global Healthcare Conference on November 10. The appearance could provide an opportunity to discuss its outlook, but no new business development was announced. Conference announcement
• Negative Sentiment: Despite beating revenue estimates, AdaptHealth reported an adjusted loss of $1.13 per share, far below the consensus loss estimate of $0.05, while revenue fell 9.1% year over year. The earnings shortfall and contraction temper the positive outlook news. Third-quarter results

AdaptHealth Price Performance

Shares of AdaptHealth stock opened at $7.31 on Monday. The business has a 50-day moving average price of $5.94 and a 200 day moving average price of $9.10. AdaptHealth has a fifty-two week low of $5.21 and a fifty-two week high of $13.43. The company has a debt-to-equity ratio of 1.53, a current ratio of 1.13 and a quick ratio of 0.98.

AdaptHealth (NASDAQ:AHCO) last released its earnings results on Tuesday, November 3rd. The company reported ($1.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.05) by ($1.08). The firm had revenue of $745.65 million for the quarter, compared to the consensus estimate of $725.87 million. AdaptHealth had a negative return on equity of 0.27% and a negative net margin of 12.90%. The company’s quarterly revenue was down 9.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.16 EPS.

Institutional Investors Weigh In On AdaptHealth

Several institutional investors and hedge funds have recently bought and sold shares of the business. Rockefeller Capital Management L.P. grew its stake in AdaptHealth by 433.0% during the 4th quarter. Rockefeller Capital Management L.P. now owns 2,585 shares of the company’s stock worth $26,000 after buying an additional 2,100 shares during the last quarter. Public Employees Retirement System of Ohio acquired a new stake in AdaptHealth in the second quarter worth $56,000. Brickley Wealth Management acquired a new stake in AdaptHealth in the third quarter worth $56,000. Citizens Financial Group Inc. RI acquired a new stake in AdaptHealth in the third quarter worth $69,000. Finally, Assetmark Inc. increased its position in AdaptHealth by 54.8% in the first quarter. Assetmark Inc. now owns 6,952 shares of the company’s stock worth $83,000 after buying an additional 2,460 shares during the period. Institutional investors and hedge funds own 82.67% of the company’s stock.

About AdaptHealth

AdaptHealth Corp. (NASDAQ: AHCO) is a provider of home medical equipment, supplies and related healthcare services in the United States. The company helps patients manage chronic conditions and recover from illness or injury outside of traditional healthcare facilities, working with individuals, caregivers, physicians and payers.

Its products and services include respiratory equipment and supplies, oxygen therapy, sleep therapy devices such as continuous positive airway pressure systems, diabetes management products, mobility and accessibility equipment, and other durable medical equipment.